Correlation Between IShares MSCI and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares MSCI and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares MSCI and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IShares MSCI Turkey and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on IShares MSCI and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares MSCI with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares MSCI and Arrowhead Pharmaceuticals.

Diversification Opportunities for IShares MSCI and Arrowhead Pharmaceuticals

  Correlation Coefficient

Very good diversification

The 3 months correlation between IShares and Arrowhead is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding IShares MSCI Turkey and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and IShares MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IShares MSCI Turkey are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of IShares MSCI i.e., IShares MSCI and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between IShares MSCI and Arrowhead Pharmaceuticals

Considering the 90-day investment horizon IShares MSCI Turkey is expected to generate 0.4 times more return on investment than Arrowhead Pharmaceuticals. However, IShares MSCI Turkey is 2.48 times less risky than Arrowhead Pharmaceuticals. It trades about 0.29 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  2,969  in IShares MSCI Turkey on September 8, 2022 and sell it today you would earn a total of  399.00  from holding IShares MSCI Turkey or generate 13.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
ValuesDaily Returns

IShares MSCI Turkey  vs.  Arrowhead Pharmaceuticals

 Performance (%) 
IShares MSCI Turkey 
IShares Performance
14 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in IShares MSCI Turkey are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, IShares MSCI reported solid returns over the last few months and may actually be approaching a breakup point.

IShares Price Channel

Arrowhead Pharmaceuticals 
Arrowhead Performance
0 of 100
Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2023. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Arrowhead Price Channel

IShares MSCI and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   

Pair Trading with IShares MSCI and Arrowhead Pharmaceuticals

The main advantage of trading using opposite IShares MSCI and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares MSCI position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against IShares MSCI as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. IShares MSCI's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, IShares MSCI's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to IShares MSCI Turkey.
The idea behind IShares MSCI Turkey and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Arrowhead Pharmaceuticals vs. Johnson Johnson
Arrowhead Pharmaceuticals vs. Bondbloxx ETF Trust
Arrowhead Pharmaceuticals vs. Fidelity MSCI Energy
Arrowhead Pharmaceuticals vs. Merck Company
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio